PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

PrEP, or pre-exposure prophylaxis, was first approved by the FDA in 2012 to prevent people exposed to HIV from becoming ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

Ireland based pharmaceutical company Gilead Sciences has said it will grant licences to six generic manufacturers to produce low cost lenacapavir, which has shown unprecedented efficacy at preventing ...

One of the most important medical breakthroughs in the fight against HIV has been the use of antiretroviral treatments for prevention. Called pre-exposure prophylaxis (PrEP), this is commonly ...

If there is an actual risk of transmission, the doctor may prescribe a 28-day course of HIV medications known as post-exposure prophylaxis (PEP). If started within 72 hours of a suspected exposure, ...

This may include abstaining from high-risk activities, using condoms, or exploring pre-exposure prophylaxis (PrEP) as a means to reduce the HIV-negative partner's susceptibility to infection. Centers ...

She added: “Addressing these widening inequalities, ramping up testing, improving access to PrEP (Pre-exposure prophylaxis) and getting people started on HIV treatment earlier will all be ...

which may result in missed HIV diagnoses or a missed opportunity to receive post-exposure prophylaxis, which can reduce the risk of HIV when taken within 72 hours after a possible HIV exposure.